Abpro Holdings, Inc. (ABPO) stock
ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW
$0.41+0.00 (+0.11%)
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Abpro cash
Cash and short-term investments held at the end of each period.
Abpro's cash was $4.24M at Jun 30, 2026. For fiscal 2025 it was $67.00K, down 97.8% from the year before. The highest annual figure on record is $7.46M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.00K | -97.8% |
| FY2024 | Dec 31, 2024 | $2.99M | +247.5% |
| FY2023 | Dec 31, 2023 | $861.00K | -88.5% |
| FY2022 | Dec 31, 2022 | $7.46M | – |
| FY2021 | Dec 31, 2021 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.24M | +110.3% |
| Q1 FY2026 | Mar 31, 2026 | $5.40M | +328.1% |
| Q4 FY2025 | Dec 31, 2025 | $67.00K | -97.8% |
| Q3 FY2025 | Sep 30, 2025 | $328.00K | +420.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.01M | +815.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.26M | +46.5% |
| Q4 FY2024 | Dec 31, 2024 | $2.99M | +215.6% |
| Q2 FY2024 | Jun 30, 2024 | $63.00K | -97.2% |
| Q1 FY2024 | Mar 31, 2024 | $220.00K | -25.5% |
| Q4 FY2023 | Dec 31, 2023 | $861.00K | -88.5% |
| Q3 FY2023 | Sep 30, 2023 | $948.15K | +401.6% |
| Q2 FY2023 | Jun 30, 2023 | $2.23M | +655.1% |
| Q1 FY2023 | Mar 31, 2023 | $295.22K | -10.7% |
| Q4 FY2022 | Dec 31, 2022 | $7.46M | – |
| Q3 FY2022 | Sep 30, 2022 | $189.03K | – |
| Q2 FY2022 | Jun 30, 2022 | $295.03K | – |
| Q1 FY2022 | Mar 31, 2022 | $330.57K | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
See a number that looks wrong?